Joseph R Young sold $436k of VERA
SVP, FINANCE, CHIEF ACCT OFFCR at Vera Therapeutics, Inc.. 15,000 shares at an average of $29.06, traded Nov 11, 2025, filed Nov 13, 2025.
Score components
- +15RoleOfficer
- +17Trade size$436k at market
- +5Share of holdings soldSold 24% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +75.5%, 3m +48.9%, 6m +39.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-280792, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 11, 2025 | SOpen-market sale Class A Common Stock | -15,000 | $29.06 | $436k | 47,839 | Nov 13, 2025 |
| Nov 13, 2025 | MOption exercise Class A Common Stock | +10,000 | $3.94 | $39k | 57,839 | Nov 13, 2025 |
| Nov 13, 2025 | MOption exercise Stock Option (right to buy)derivative | -10,000 | $0.00 | $0 | 48,589 | Nov 13, 2025 |
Related signals
Other insiders at Vera Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $685k 18,500 shares | -7% | |
| 10Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $650k 18,500 shares | -7% | |
| 11Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $680k 18,500 shares | -7% | |
| 11Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $702k 18,500 shares | -7% | |
| 20Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $2.0M 46,250 shares | -16% | |
| 35Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $2.0M 46,250 shares | -23% | |
| 26Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $702k 18,500 shares | -9% | |
| 26Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $680k 18,500 shares | -8% | |
| 30Weak | Vera Therapeutics, Inc. | Marshall Fordyce PRESIDENT AND CEO | $1.0M 22,951 shares | -9% | |
| 39Weak | Vera Therapeutics, Inc. | Robert Brenner Chief Medical Officer | $90k 2,151 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.